A rigorous 16-year prospective cohort analysis from the Framingham Heart Study has quantified the relationship between midlife vitamin D status and tau pathology in Alzheimer’s-vulnerable brain tissue. Among 793 cognitively normal participants, researchers found that higher serum 25-hydroxyvitamin D levels, measured between 2002–2005, correlated with significantly reduced tau accumulation in two critical brain regions: the entorhinal cortex and parahippocampal gyrus, where Alzheimer’s pathology initiates. The association demonstrated a linear, dose-dependent pattern across the complete spectrum of measured vitamin D concentrations, indicating that vitamin D benefits were not confined to a specific threshold but rather increased continuously with higher levels. Interestingly, this protective tau association was not observed for amyloid-beta plaque accumulation, suggesting a mechanistically selective relationship. These findings provide moderate evidence for vitamin D’s potential neuroprotective role in Alzheimer’s disease pathogenesis, though clinical implementation awaits prospective intervention trials.
Was this article helpful?
